Stem, Inc.
NYSEStem, Inc. just reported Q1 results into one of the most charged short-positioning setups it has seen all year. Q1 delivered a classic beat-miss split. EPS came in at -$2.22, better than the -$2.30 consensus. Revenue landed at $29 million, short of the $33.8 million estimate. The company held its full-year 2026 sales guidance at $140–$190 million, bracketing analyst expectations of…
Snapshot as of 7 May 2026
Stem, Inc. just reported Q1 results into one of the most charged short-positioning setups it has seen all year. Q1 delivered a classic beat-miss split. EPS came in at -$2.22, better than the -$2.30 consensus. Revenue…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for STEM — free to start on ORTEX.
Sign up for free →Open STEM on ORTEX